Larimar Therapeutics
LRMR
#8139
Rank
โ‚ฌ0.29 B
Marketcap
2,86ย โ‚ฌ
Share price
-2.48%
Change (1 day)
-7.40%
Change (1 year)

EPS for Larimar Therapeutics (LRMR)

EPS in 2026 (TTM): -1,67ย โ‚ฌ

According to Larimar Therapeutics's latest financial reports the company's current EPS (TTM) is -1,78ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of -2,01ย โ‚ฌ a decrease over its 2024 EPS that were of -1,19ย โ‚ฌ.

EPS history for Larimar Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-1,67ย โ‚ฌ-17.01%
2025-2,01ย โ‚ฌ70%
2024-1,19ย โ‚ฌ
2022-1,40ย โ‚ฌ-48.15%
2021-2,71ย โ‚ฌ-14.27%
2020-3,16ย โ‚ฌ